Eli Lilly (LLY) Return on Capital Employed Growth (5y) (2014 - 2026)

Eli Lilly (LLY) Return on Capital Employed Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 2,394.00
Dec 31, 2025 1,641.00
Sep 30, 2025 1,875.00
Jun 30, 2025 1,836.00
Mar 31, 2025 1,230.00
Dec 31, 2024 1,157.00
Sep 30, 2024 761.00
Jun 30, 2024 1,066.00
Mar 31, 2024 588.00
Dec 31, 2023 1,260.00
Sep 30, 2023 1,002.00
Jun 30, 2023 420.00
Mar 31, 2023 496.00
Dec 31, 2022 975.00
Sep 30, 2022 1,091.00
Jun 30, 2022 1,199.00
Mar 31, 2022 976.00
Dec 31, 2021 768.00
Sep 30, 2021 930.00
Jun 30, 2021 751.00